Skip to content
GovLens is in
free beta
— full access while we build.
Join the beta →
×
│
European Parliament
Methodology
About
English
Nederlands
Deutsch
Français
Español
Italiano
Polski
Português
Română
Light
Gov
Lens
European Legislative Intelligence
⌘K
Search
⌘K
Sign in
Enterprise
Light
Parliament
🌍
All
🇪🇺
EU
🇩🇪
DE
🇫🇷
FR
🇮🇹
IT
🇪🇸
ES
🇵🇱
PL
🇳🇱
NL
🇧🇪
BE
🇸🇪
SE
🇦🇹
AT
🇩🇰
DK
🇫🇮
FI
🇮🇪
IE
🇪🇪
EE
Feed
Today
EU Profile
Data
/
Learn
← 🇩🇪 Bundestag
/
KLEINE ANFRAGE
dip-276047
Hintergründe zur Finanzierung der Entwicklung neuer Therapeutika gegen SARS-CoV-2
Stage
other
Updated
4mo ago
View source ↗
(
insgesamt 8 Einzelfragen)
Was this useful?